Nifty 17401.65 (1.37%)
Sensex 58461.29 (1.35%)
Nifty Bank 36508.25 (0.39%)
Nifty IT 36157.85 (2.06%)
Nifty Financial Services 17982.9 (1.26%)
Adani Ports 739.10 (4.40%)
Asian Paints 3180.60 (1.35%)
Axis Bank 676.10 (-0.52%)
B P C L 378.85 (2.74%)
Bajaj Auto 3328.40 (2.43%)
Bajaj Finance 7180.50 (2.01%)
Bajaj Finserv 17758.15 (2.16%)
Bharti Airtel 732.55 (1.43%)
Britannia Inds. 3578.50 (1.22%)
Cipla 921.25 (-0.74%)
Coal India 159.30 (2.41%)
Divis Lab. 4777.30 (0.53%)
Dr Reddys Labs 4662.75 (1.22%)
Eicher Motors 2451.55 (0.54%)
Grasim Inds 1723.85 (2.63%)
H D F C 2807.80 (3.85%)
HCL Technologies 1184.70 (2.42%)
HDFC Bank 1525.75 (1.40%)
HDFC Life Insur. 705.30 (1.65%)
Hero Motocorp 2472.70 (1.00%)
Hind. Unilever 2383.30 (1.64%)
Hindalco Inds. 432.10 (1.69%)
I O C L 120.65 (2.51%)
ICICI Bank 722.40 (-0.73%)
IndusInd Bank 945.55 (1.27%)
Infosys 1748.25 (1.94%)
ITC 225.45 (1.60%)
JSW Steel 646.75 (1.50%)
Kotak Mah. Bank 1964.25 (0.56%)
Larsen & Toubro 1789.20 (0.18%)
M & M 849.55 (1.78%)
Maruti Suzuki 7324.95 (0.71%)
Nestle India 19503.20 (0.54%)
NTPC 128.70 (0.78%)
O N G C 144.00 (1.23%)
Power Grid Corpn 214.50 (3.52%)
Reliance Industr 2482.85 (0.64%)
SBI Life Insuran 1188.05 (1.99%)
Shree Cement 26289.80 (0.76%)
St Bk of India 477.00 (0.36%)
Sun Pharma.Inds. 766.25 (2.80%)
Tata Consumer 773.25 (0.06%)
Tata Motors 479.10 (0.81%)
Tata Steel 1112.40 (2.76%)
TCS 3642.90 (1.82%)
Tech Mahindra 1629.65 (2.65%)
Titan Company 2386.50 (1.11%)
UltraTech Cem. 7323.20 (0.01%)
UPL 698.20 (1.12%)
Wipro 646.80 (1.89%)
INFY

Sequent Scientific Ltd.

₹153.
Not a customer?

Open free demat account
& trade instantly

Investment Ratings

As per analysts rating in the last 6 months, the recommendation is to HOLD Sequent Scien.

  • Master Rating:
  • Sequent Scientific has an operating revenue of Rs. 1,391.10 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 10% is healthy, ROE of 13% is good. The company has a reasonable debt to equity of 13%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 52 which is a POOR score indicating inconsistency in earnings, a RS Rating of 2 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 146 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Sequent Scientific Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Ratings

Eps And Sales Estimates

Sequent Scientific Ltd Synopsis

NSE-Medical-Diversified

Sequent Scientific is involved in the business activities of Manufacture of veterinary preparations. Company’s Total Operating Revenue is Rs. 265.46 Cr. and Equity Capital is Rs. 49.67 Cr. for the Year ended 31/03/2021. Sequent Scientific Ltd. is a Public Limited Listed company incorporated on 28/06/1985 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1985PLC036685 and registration number is 036685.
  • Market Cap

    INR 3,800.08 Cr

  • Sales

    INR 236.81 Cr

  • Shares in Float

    11.43 Cr

  • No of Funds

    61 K

  • Yield

    0.33%

  • Book Value

    3.69

  • U/D Vol Ratio

    0.7

  • LTDebt/Equity

    2%

  • Alpha

    -0.13

  • Beta

    1.22

Sequent Scientific Ltd Ownership
Sequent Scientific Ltd Management

Sequent Scientific Ltd Financials

INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Total ShareHolders Funds Annual Cr 1029.511886.217917.791948.6171257.33
Fixed Assets Annual Cr 70.12173.12952.45726.804220.114
Total Non Current Assets Annual Cr 983.557885.698932.448836.931081.876
Total Current Assets Annual Cr 118.565111.67286.445140.544368.46
Total Assets Annual Cr 1102.122997.371018.893977.4741450.336
INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Book Value Per Share Annual Rs 41.450635.681237.17738.9251.5858
ROE Annual % 3.112.40.8242.840
ROCE Annual % 4.473.0710.23-1.15
Total Debt to Total Equity Annual -----
EBDIT Annual Margin % 20.8116.1810.015.54-12.66

Sequent Scientific Ltd Technicals

EMA & SMA

CURRENT PRICE

153 (0.07)

    • Bullish Moving Averages 1
    • Bearish Moving Averages 15

EMA

  • 20 Day

    170.88

  • 50 Day

    191.4

  • 100 Day

    212.73

  • 200 Day

    243.67

Sequent Scientific Ltd Resistance and support

152.79 PIVOT

  • First Resistance

    155.07

  • Second Resistance

    157.24

  • Third Resistance

    159.52

  • First Support

    150.62

  • Second Support

    148.34

  • Third Support

    146.17

  • RSI

    30.76

  • MFI

    30.34

  • MACD

    -12.01

  • MACD signal line

    -10.36

Sequent Scientific Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,481,900 55,363,784 37.36%
Week 1,698,119 68,094,556 40.1%
1 Month 1,390,290 63,897,712 45.96%
6 Month 1,772,350 61,855,004 34.9%

Sequent Scientific Ltd Price change analysis

-22.6

Over 1 month

Low High
144.75 194.9

-78.85

Over 3 month

Low High
144.75 239.7

-111.7

Over 6 months

Low High
144.75 336.5

-8.85

Over Year

Low High
144.75 336.5

Similar Stocks

News

SEQUENT SCIENTIFIC LTD. - 512529 - Compliance Under Regulati

In terms of Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Read More

Sequent Scientific Ltd - 512529 - Intimation Under Regulatio

With reference to the captioned subject, we would like to inform you that upon voluntary application made by Elysian Life Science Private Li Read More

Sequent Scientific Ltd - 512529 - Announcement under Regulat

Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Read More

Sequent Scientific Ltd - 512529 - Announcement under Regulat

Pursuant to the provision of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Read More

Q2FY22 Result Quarterly Announced for Sequent Scientific Ltd

Financial Highlights: Revenues at Rs. 3,506 Million PAT after minority interest at Rs. 143 Million PAT margin at 4.1% Commenting on the Co Read More

Blogs

FAQs